Kodiak Sciences Inc. KOD
32.35
(0.87)
(2.62%)
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 0.0×
Follow KOD
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
4.06 | 0.17 | 18.74 | 28.97 | 30.93 | 11.36 | 9.26 | 6.93 | 6.72 | 4.72 |
Net Debt/EBITDA |
0.56 | (0.34) | 3.41 | 6.89 | 6.78 | 2.15 | 0.91 | 1.13 | 1.05 | 1.01 |
Debt/Assets |
0.85% | 305.83% | 0.00% | 0.56% | 7.03% | 19.46% | 26.70% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | (0.14) | 0.00 | 0.01 | 0.09 | 0.27 | 0.41 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.94 | 0.63 | 0.70 | 0.83 | 0.63 | 0.68 | 0.62 | 0.59 | 0.67 | 0.59 |
Capex/Depreciation |
(3.00) | (0.38) | (1.19) | (0.65) | (1.66) | (7.20) | (4.74) | (1.65) | (0.01) | (0.02) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 31.13% | 50.88% | (458.06%) | (21.92%) | (22.07%) | (35.04%) | (60.72%) | (74.22%) | (84.70%) | (149.49%) | |
| (226.70%) | (363.80%) | (86.85%) | (21.00%) | (18.66%) | (27.08%) | (42.50%) | (45.46%) | (43.24%) | (66.94%) | |
ROIC |
0.00% | 0.00% | 0.00% | (282.62%) | 0.00% | (154.82%) | (157.77%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(181.14%) | 461.45% | (47.79%) | (14.42%) | (14.07%) | (37.53%) | (68.14%) | (70.77%) | (70.88%) | (90.35%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.33) | (2.38) | (1.98) | (1.05) | (1.98) | (4.74) | (4.86) | (3.73) | (2.24) | (2.57) |
Cash per Share |
1.33 | 0.19 | 5.89 | 8.89 | 21.18 | 14.12 | 9.17 | 5.45 | 3.20 | 3.94 |
Shareholders Equity per Share |
(5.70) | (9.15) | 5.80 | 9.12 | 18.82 | 12.81 | 8.35 | 5.07 | 2.86 | 2.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(5.70) | (9.15) | 5.80 | 9.12 | 18.82 | 12.81 | 8.35 | 5.07 | 2.86 | 2.96 |
Free Cash Flow |
(16.82) | (17.86) | (29.61) | (39.58) | (90.43) | (245.57) | (253.82) | (195.61) | (117.72) | (136.51) |
Working Capital |
7.68 | (7.56) | 85.62 | 327.52 | 940.58 | 670.13 | 433.51 | 247.58 | 146.36 | 169.28 |
Capital Expenditures |
(0.77) | (0.21) | (0.58) | (0.44) | (7.00) | (63.30) | (47.36) | (41.43) | (0.40) | (0.51) |
Net Current Asset Value |
(43.01) | (70.39) | 85.09 | 325.72 | 765.41 | 493.91 | 255.54 | 75.72 | (13.35) | 20.67 |
| Other line items | ||||||||||
Quick Ratio |
3.84 | 0.15 | 18.29 | 28.73 | 30.84 | 11.31 | 9.12 | 6.84 | 6.57 | 4.61 |
Depreciation/Fixed assets |
0.14 | 0.36 | 0.45 | 0.67 | 0.82 | 0.21 | 0.18 | 0.21 | 0.26 | 0.31 |
Cash ROIC |
56.84% | 33.37% | (17.21%) | (5.87%) | (4.65%) | (14.23%) | (24.05%) | (49.82%) | (68.96%) | (60.25%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.23) | (2.35) | (1.94) | (1.03) | (1.82) | (3.52) | (3.95) | (2.94) | (2.23) | (2.56) |
Capex per Share |
(0.11) | (0.03) | (0.04) | (0.01) | (0.15) | (1.22) | (0.91) | (0.79) | (0.01) | (0.01) |
Average Payables |
2.04 | 2.22 | 2.20 | 1.83 | 5.63 | 10.54 | 10.78 | 11.37 | 8.76 | 8.39 |
Average Assets |
7.56 | 7.68 | 47.72 | 225.53 | 713.11 | 985.78 | 785.42 | 573.00 | 407.48 | 343.56 |
Average Common Equity |
(55.04) | (54.91) | 9.05 | 216.10 | 603.06 | 762.04 | 549.74 | 350.97 | 208.03 | 153.84 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates